Fraunhofer has invested in Enerthing, which is launching IoT products powered by solar foils invented in partnership with Fraunhofer ISE.

Health for Life Capital II has achieved its first close thanks to commitments from strategic partners Danone, Novartis, Lesaffre, Wright Medical, Unicéréales and Bel.

Alicia Irurzun-Lafitte has departed from a principal position at M Ventures for a partner role at another pharmaceutical firm's corporate venturing fund, UCB Ventures.

ETH’s Paul Scherrer Institute has launched Araris Biotech to deliver production technology for site-specific ADCs that enable them to be used without being engineered from each patient.

Satt Sud-Est spinouts Click4Tag, C4Hydro and C4Biocontrol will merge to boost the commercialisation of microbe monitoring technologies built on research from six institutions.

Hearst and Alphabet-backed music services group Kobalt is gearing up to raise its largest funding round to date, in a deal potentially sized at more than $100m.

The Salesforce-backed online insurance platform is reportedly valued at nearly $1bn having raised funding from investors including CreditEase.

Cemex Ventures founding member and adviser Pedro Irujo left the unit in December 2018 after two years, and 13 years at its parent company.

Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.

Vilmorin & Cie has joined fellow corporates including BNP Paribas, Naval Group and MGEN as an investor in the targeted $87.5m PSL Innovation Fund.